Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
IMS Health and Reltio have announced that IMS Health is offering Reltio Cloud with its Nexxus™ Commercial Application Suite and IMS One™ platform. Through the alliance, IMS Health will offer life sciences organizations new options for fast, scalable ...
read more
Veristat, a full service Clinical Research Organization (CRO), announced that it has strengthened its statistical consulting and adaptive design expertise with the appointment of Mark Chang, PhD to the newly created position of Senior Vice President ...
read more
Averica Discovery Services Inc., an analytical development Contract Research Organization (CRO) based in the Greater Boston area, and Dalton Pharma Services, a contract provider of integrated chemistry, drug development, and manufacturing services ...
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has announced research showing many pharmaceutical and clinical research organizations (CROs) support the use ...
read more
AMRI has announced that its Buffalo, N.Y. site has been selected to participate as a Dedicated Chemical Biology Consortium (CBC) Center for the Experimental Therapeutics (NExT) Program, centered at the Frederick National Laboratory for Cancer ...
read more
Wolfe Laboratories has announced that Frank Tagliaferri, Ph.D., has been appointed Vice President, Pharmaceutical Development, effective immediately.
read more
PAREXEL International Corporation, a global biopharmaceutical services provider, has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to...
read more
Eurofins Lancaster Laboratories, part of Eurofins Scientific has announced strategic plans for the expansion of its Dungarvan, Ireland campus, including development of a new building as well as expansion of its current facility.
read more
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has signed a three-year agreement with Pfizer Inc.
read more
PYRAMID Laboratories, Inc. a clinical and commercial contract aseptic drug product developer and manufacturer is proud to announce it is celebrating 28 years of providing cGMP services to the Pharmaceutical and Biotech industries during July 2016.
read more
Frontage Laboratories, Inc., a Contract Research Organization based in Pennsylvania, New Jersey and China, announced on June 4 that its affiliate company, Frontida BioPharm, Inc. acquired certain assets from a wholly owned US subsidiary of Sun Pharma...
read more
Synexus, a Site Management Organization (SMO), dedicated to the recruitment of patients’ and hands-on conduct of clinical trials on behalf of pharmaceutical, biotech and CRO clients, has opened a new Dedicated Clinical Research Site in Frankfurt.
read more
SGS, a bio/pharmaceutical analytical and bioanalytical contract solutions provider, will further expand its higher order structure analysis services for proteins, at its West Chester, PA, facility, with an investment in Hydrogen Deuterium Exchange ...
read more
Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, has announced the opening of its clinical supply facility, located within its 200,000 sq. ft....
read more
Amyris has entered into a research agreement with a commercial license option with Janssen Biotech, Inc., part of Janssen Pharmaceutical Companies. Under the terms of the agreement, facilitated by Johnson & Johnson Innovation, the collaboration will ...
read more